SCHLUMBERGER
21.9.2022 11:01:40 CEST | Business Wire | Press release
Schlumberger today announced the commercial release of the Schlumberger Enterprise Data Solution, which is powered by Microsoft Energy Data Services. Developed to deliver the most comprehensive capabilities for subsurface data—in alignment with the emerging requirements of the OSDU™ Technical Standard, a new open industry standard for energy data—the Enterprise Data Solution makes data accessible on an unprecedented scale for the global energy industry.
This technology enables customers to integrate subsurface data with technologies and workflows from multiple vendors. It is a single, open and interoperable platform with embedded artificial intelligence (AI) and powerful data management tools, which support and accelerate scalable, data-driven decision making at all levels of the organization.
Microsoft Energy Data Services is a fully managed, enterprise-grade OSDU data platform co-built with domain expertise from Schlumberger, which powers the Enterprise Data Solution. Supported by a global network of specialist development centers around the world including the U.S., India and Europe, the companies work together to continuously bring new capabilities to market, as well as to provide sales, service and technical support.
“A global cloud-based data solution, developed by Schlumberger and powered by the Microsoft Cloud, means the energy industry can confidently and fully embrace its digital transformation,” said Rajeev Sonthalia, president, Digital & Integration, Schlumberger. “Together, Schlumberger’s energy and subsurface data expertise and Microsoft’s experience in scaling cloud-based data solutions in an open interoperable data platform, have successfully unlocked the full potential of data. Accelerating time to value from AI and digital solutions creates significant new opportunities to increase productivity and boost performance. This is the future of data management for the energy industry.”
"A critical aspect of the energy transition process is harnessing data solutions that improve decision making and increase operational efficiency,” said Scott Guthrie, executive vice president, Cloud + AI Group, Microsoft. “The Schlumberger Enterprise Data Solution, powered by Microsoft Energy Data Services and built on Microsoft Azure, enables organizations in the energy industry to gain greater control of their data and unlock insights that accelerate their journey to data modernization.”
This fully integrated cloud-native enterprise data solution enables end-to-end data-driven workflows scalable to customers’ organizations. Full upstream data capabilities will expand from subsurface to production to well construction and welcome the transition to new and low-carbon energy sources. The Enterprise Data Solution will also accelerate advanced workflows to screen, assess and design carbon capture, utilization and storage (CCUS) projects to support rapidly growing demand for large-scale CO2 sequestration. Data previously held in poorly connected silos can now flow freely across an unbroken data landscape to allow AI and automation to work at previously unimagined scale.
Extraordinary new capabilities and workflows promise to deliver faster and more accurate decision making, reducing the time it takes for customers to extract additional value from their digitalization strategies.
Early adopters of these exciting new technologies include both PETRONAS and Chevron. PETRONAS has liberated petabytes of E&P data for users, integrating 12 corporate data stores to a single data platform and improving data management efficiency and optimizing infrastructure. Chevron is working in partnership with Schlumberger and Microsoft to accelerate the creation of digital technologies across its value chain globally.
“Chevron is committed to our collective vision for digital innovation in energy solutions and to working collaboratively to deliver this vision. It is great to see our strategic partners, Microsoft and Schlumberger, embracing the open, industry-data foundation to build innovative products at enterprise scale,” said Kevin Chambers, VP Subsurface, Chevron. “As an early adopter of the OSDU™ Data Platform, Chevron believes ‘the best is yet to come,’ as we continue to drive innovative capabilities in the OSDU community via our people and industry collaborations and synergies.”
Today’s announcement was made during the Schlumberger Digital Forum 2022, which is taking place this week in Lucerne, Switzerland.
About Schlumberger
Schlumberger (NYSE: SLB) is a technology company that partners with customers to access energy. Our people, representing over 160 nationalities, are providing leading digital solutions and deploying innovative technologies to enable performance and sustainability for the global energy industry. With expertise in more than 120 countries, Schlumberger collaborates to create technology that unlocks access to energy for the benefit of all.
Find out more at www.slb.com
Cautionary Statement Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the federal securities laws—that is, any statements that are not historical facts. Such statements often contain words such as “expect,” “may,” “can,” “believe,” “plan,” “estimate,” “intend,” “anticipate,” “should,” “could,” “will,” “likely,” “goal,” “objective,” “aspire,” “aim,” “potential,” “promise”, “projected” and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as forecasts or expectations regarding the deployment of, or anticipated benefits of, digital technologies and partnerships. These statements are subject to risks and uncertainties, including, but not limited to, the inability to recognize intended benefits from digital strategies, initiatives or partnerships; and other risks and uncertainties detailed in Schlumberger’s most recent Forms 10-K, 10-Q, and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of any such development changes), or should underlying assumptions prove incorrect, actual results or outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, Schlumberger disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220920006108/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom